Clinical trial
Midazolam Effect on Agitation Postnasal Surgery: A Double Blinded Randomized Controlled Trial
NCT05165914 is registered in ClinicalTrials.gov with Jordanian Royal Medical Services as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Midazolam Effect on Agitation Postnasal Surgery: A Double Blinded Randomized Controlled Trial
- Lead sponsor
- Jordanian Royal Medical Services
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- May 27, 2021
- Completion date
- December 1, 2021
- Enrollment
- 100 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
agitation